Sector
PharmaceuticalsOpen
₹104.4Prev. Close
₹104.5Turnover(Lac.)
₹5.22Day's High
₹104.5Day's Low
₹104.452 Week's High
₹153.9552 Week's Low
₹75.55Book Value
₹0Face Value
₹10Mkt Cap (₹ Cr.)
49.07P/E
44.09EPS
2.37Divi. Yield
01 Jul 2024
12:00 AM
Board Meeting
Agenda : Audited Result
4 Sep 2023
12:00 AM
AGM
Announcement Date: 04 Sep, 2023
4 Sep 2023
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Dec-2020 |
|---|---|---|---|---|
Equity Capital | 4.54 | 4.54 | 3.34 | 3 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 6.78 | 6.49 | 1.44 | 0.23 |
Net Worth | 11.32 | 11.03 | 4.78 | 3.23 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Dec-2020 | Mar-2020 |
|---|---|---|---|
Revenue | 6.06 | 1.42 | 16.71 |
yoy growth (%) | 325.6 | -91.46 | |
Raw materials | -4.27 | -0.87 | -10.61 |
As % of sales | 70.41 | 61.16 | 63.48 |
Employee costs | -0.79 | -0.06 | -2.56 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Dec-2020 |
|---|---|---|
Profit before tax | 0.16 | 0.3 |
Depreciation | -0.11 | -0.02 |
Tax paid | -0.01 | -0.07 |
Working capital | 0.57 | |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Dec-2020 |
|---|---|---|
Growth matrix (%) | ||
Revenue growth | 325.6 | |
Op profit growth | 20.8 | |
EBIT growth | -3.64 | |
Net profit growth | -33.76 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Gross Sales | 62.52 | 35.14 | 26.76 | 6.07 |
Excise Duty | 0 | 0 | 0 | 0 |
Net Sales | 62.52 | 35.14 | 26.76 | 6.07 |
Other Operating Income | 0 | 0 | 0 | 0 |
Other Income | 0.22 | 0.34 | 0.04 | 0 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.65 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,519.8 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.5 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.45 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,636 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Kalpesh Pravinchandra Ladhawala
Whole-time Director
Tanmaykumar Ashwinbhai Shah
Executive Director
Sejal Ladhawala
Executive Director
Abhishekkumar Dineshkumar Patel
Executive Director
Fenil Prakashkumar Sha
Executive Director
Jigneshkumar Dineshkumar Modi
Executive Director
Krunal Jashubhai Patel
Executive Director
Nidhi YogeshKumar Shah
Executive Director
Divyanshu Subhashchandra Raval
Addtnl Non-Exe Dir &Indpnt Dir
Jayshukh Ramjibhai Detroja
Addtnl Non-Exe Dir &Indpnt Dir
Rupesh Himatla Shah
Addtnl Non-Exe Dir &Indpnt Dir
Tapan Natverlal Patel
Addtnl Non-Exe Dir &Indpnt Dir
Nehalkumar Jasvantlal Shah
Company Secretary
Priyanka Shah
Independent Director
Megha Shah
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Walpar Nutritions Ltd
Summary
The Company was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of M/s Walpar Healthcare, pursuant to a Deed of Partnership dated November 16, 2009. Subsequently, the Constitution of Partnership Firm were changed on March 9, 2015, August 15, 2017 and June 12, 2020 by admission and retirement of Partners. M/s. Walpar Healthcare was thereafter incorporated and converted from a erstwhile Partnership Firm to a Public Limited Company under Part I Chapter XXI of the Companies Act, 2013 in the name of Walpar Nutritions Limited and received a Certificate of Incorporation dated December 4th, 2020 from the Central Registration Center, Ministry of Corporate Affairs. The Company is primarily engaged in manufacturing, marketing and trading of Pharmaceuticals, Nutraceutical, Herbal and Ayurvedic commodities online and offline.During the year 2021, the Company allotted 3,41,220 Equity Shares of having Face Value of Rs. 10/- each at a price of Rs. 50/- per share including premium of Rs. 40/- per share on preferential basis.
Read More
What is the Walpar Nutritions Ltd share price today?
The Walpar Nutritions Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is Rs.₹104.5 today.
What is the Market Cap of Walpar Nutritions Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Walpar Nutritions Ltd is ₹49.07 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Walpar Nutritions Ltd?
The PE and PB ratios of Walpar Nutritions Ltd is 44.09 and 3.68 as of 22 Jul ‘24
What is the 52 Week High and Low of Walpar Nutritions Ltd?
The 52-week high/low is the highest and lowest price at which a Walpar Nutritions Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Walpar Nutritions Ltd is ₹75.55 and ₹153.95 as of 22 Jul ‘24
What is the CAGR of Walpar Nutritions Ltd?
Walpar Nutritions Ltd's CAGR for 5 Years at 12.89%, 3 Years at 30.98%, 1 Year at 39.24%, 6 Month at -21.46%, 3 Month at -17.06% and 1 Month at -5.43%.
What is the shareholding pattern of Walpar Nutritions Ltd?
The shareholding pattern of Walpar Nutritions Ltd is as follows:
Promoters - 71.23 %
Institutions - 0.00 %
Public - 28.77 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
